Wasatch Advisors LP Increases Stake in Journey Medical Corp (DERM) to 10%

Wasatch Advisors LP has filed a Schedule 13G/A (Amendment No. 2) with the SEC, reporting a significant increase in its stake in Journey Medical Corp (DERM). As of the event date on March 31, 2026, the investment adviser reported beneficial ownership of 2,133,370 shares of common stock, representing 10.0% of the company's outstanding shares. This is a substantial increase from its previously reported position of 1,316,275 shares. Of the total shares held, Wasatch Advisors LP maintains sole voting power over 1,979,366 shares and sole dispositive power over all 2,133,370 shares. The filing indicates that the securities were acquired in the ordinary course of business and are not held for the purpose of influencing or changing the control of the issuer. The firm, based in Salt Lake City, Utah, is filing as an investment adviser in accordance with Rule 13d-1(b).